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The regulatory effect of endogenously synthesized 
eicosanoid m.etabolites on the expression of tissue 
inhibitor of m.etalloproteinases (TIMP) , interstitial 
collagenase, and 92-kDa gelatinase by hum.an m.ac-
rophages was exam.ined. TIMP and m.etalloproteinase 
production were stim.ulated with three agonists that 
produce distinct patterns of eicosanoid synthesis: 
lipopolysaccharide (10 pg/m.l), denatured collagen 
(10 pg/m.l), or zym.osan (1 m.g/m.l). Indom.ethacin 
(3 pg/m.l) or MK886 (3 pM), a specific inhibitor of 
5-lipoxygenase, was used to exam.ine the role of 
e n dogenous m.etabolites of arachidonic acid. Regard-
less of the agonis·t used, TIMP production by m.acro-
phages was inhibited 65% by indom.ethacin, synthesis 
of interstitial collagenase was reduced 70%, and ex-
pression of 92-kDa gelatinase was decreased 40%. In 
contrast, inhibition of leukotriene synthesis had no 
effect on m.etalloproteinase or TIMP production. The 
a gonist-stim.ulated increase in TIMP and collagenase 
p r oduction was directly correlated to the cum.ulative 
prostaglandin E2 level induced by the agonist used. 
However, if response to an agonist was poor, the 
R emodeling of connective ti ssue is important in tissue m orphogenesis, inflammation, and repair. Matrix metaLloprotein ases are key enzym es in th ese processes . T he human mononucl ear phago-cyte subserves major immunomodulatory and deg-
radative fun ctions in the skin, and we have shown previously that 
this cell type expresses matri x metalloprotein ases in granuloma 
annulare, necrobiosis lipoidica diabeticorum, and wound healing 
[1,2]. Human macrophages produce at least three en zymes from the 
metaUopro tein ase gene fa mily (interstitial collagenase , 92- kDa 
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exogenous addition of prostaglandin E2 could not 
increase TIMP or collagenase production m.ore than 
twofold, indicating an im.portant perm.issive effect of 
the agonist on the regulation of each protein's ex-
pression. The m.echanism. of indom.ethacin inhibition 
of TIMP and collagenase production was studied by 
labeling the cells with fSS]-m.ethionine and perform.-
ing im.m.unoprecipitation using specific antiserum.. 
Indom.ethacin m.arkedly inhibited the lipopolysac-
charide-induced biosynthesis of both TIMP and col-
lagenase. Northern analysis revealed parallel suppres-
sion ofTIMP and collagenase steady-state m.RNA levels 
by indom.ethacin, indicating pretranslational control. 
The regulation ofin1lam.m.atory-cell TIMP and intersti-
tial collagenase expression by prostaglandin E2 suggests 
that therapy inhibiting the cellular response to pros-
taglandins m.ay be useful in cutaneous and system.ic 
disease states involving m.acrophage-m.ediated con-
nective-tissue destruction. Key words: eicosalloid/wOlmd 
healing/collagenase/arachidonic acid. ] I'lVest Dermatol 104: 
52-57, 1995 
gelatinase, and stromelysin), which difFer in their substrate speci-
fi city and biochemical characteristics [3-5]. Interstitial collagenase 
is uniquely capable of cleaving the triple helix of native collagen 
types I, II , III , and X, thus i.nitiating their degradation [5-8]. The 
92-kDa gelatinase is highly efficient in degrading denatured colla-
gens of all types, but also cleaves native types IV and V collagens 
and insoluble elastin [3,9]. Stromelysin has broad substrate speci-
fi city, degrading proteoglycans, fibronectin, lamillin, and types IV 
and IX collagens in their nonhelical domains [10,11). In addition to 
these enzymes, macrophages secrete tissue inhibitors of metallo-
protei.l1 :1scS (TIMP and TIMP-2) [12]. These inhibitors bind the 
metalloproteinases wi th high affinity (K; = 1.0 - "10 M) to control 
their catalytic activity [1.3]. Thus, the mechanisms that regulate the 
expression of macrophage metalloenzymes and their inhibitors are 
of substantial interest, 
Also synthesized by macrophages during inflammation are a 
vari e ty of arachidonic acid metabolites, i.ncluding prostaglandin 
(PG) E2 , thromboxane (TX) A 2 , and leukotrienes (LT) B4 and C 4 
[14,15]. In studies by C orcoran et al [16] and Wahl et al [17-19], it 
ha s been shown that the net collagenase activity of human mono-
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cytes and guinea pig macrophages is dependent upon the concom-
itant synth esis of PGE2 . T hese studies demonstrated that indo-
methacin treatment of the cell s inhibited their collagenase activity, 
whereas re-addition of PGE2 in the presence of indomethacin 
recon stitu ted the activity. Recent work from our group has dem-
on strated that tllis PG-dependent mechanism is an early step in th e 
collagen- stim ula ted expression of collagenase by human macro-
phages [ZO]. However, a variety of metalloproteinases are secreted 
by macrophages, and overall catalytic activity is determined by 
specific en zym e levels as well as by the simultaneous presence 
of T IMP. To sort o u t the quantitative relations between metallo-
proteinases, th e ir major tissue-derived inllibitor (TIMP), and the 
eicosanoid products made by hum an mononuclear phagocytes, we 
performed a deta.iled study of th e regulatory contribution of the 
eicosan oid products synthesized by macrophages to their matrix-
degrading activities. Our data demon strate that in addition to 
matrix m etalloproteinases, T IMP expression is regulated by endog-
enous PG synthes is in human macrophages. T llis effect is likely to 
influence significantly the efficacy of nonsteroidal anti- inflamma-
tory drugs on connective-tissue turn over. 
MATERJALS AND METH ODS 
Reagents Lipopolysaccharide (LPS) was obtained fiom Sigma (catalog 
no. L-4255, St. Louis, MO) , as were zymosan and indomethacin . Type I 
collagen was prepared fi,om rat-tail tendon by acetic acid extraction [21] , 
and was denatured before use by heating at 65°C for 20 min . T he amount 
of endotoxin present was less than 0.03 ng/ ml. an amount insufficient to affect 
metalloproteinase or TIMP synthesis. I-BOP, [l S-[l a ,2a(Z),3{3(lE,3S).4a]]-
7 _[3_[3_hydrox'Y-4- l4-iodophenox'Y ]-l-butenyl]7 -oxabicyclo[2.2 . 1]hept-2-yl]-
5-hepteneoic acid, a stable ana logue ofTXA2, was purchased from Cayman 
Chemical Co. (Ann Arbor, Ml) . OKY 1581, a stable prostacyclin analogue, 
was the gift of O no Corp. (Osaka, Japan) . MK886 was the kind gift of Dr. 
Ford-Hutchinson (Merck Frosst. Quebec, Canada). 
Cell Culture Human alveolar macrophages, harvested fi'om healthy 
adul t volunteers by sa line bronchoa lveolar lavage (4), were used as a 
prototypic cell SOllrce of human macrophages. To provide adequate ce ll 
yie ld, ollly cigarette smokers (more than one pack per day) were selected. 
T he cells obtained were greater than 95% macrophages, as determined by 
differential coun ting of Wright-stained cytocentrifuge preparations. T he 
remaining cells were primari ly lymphocytes. T he cells were incubated for 
1 h at 37°C to allow attachment, then refed with a 1:1 (v/v) mixture of 
Ham's F-12/Dulbecco's modification of Eagle's medium (Ham's/DME) 
supplemented with 10%, feta l bovine serum. Cell cultures were maintained 
in humidified 95% air/5% CO2, 
Generation and Collection of Conditioned Media Experiments 
were performed by pretreating macrophages with the eicosanoid-synthesis 
inhibi tor of interest for 15-30 min before agonist stimulation. After washing 
twice with serum-free Ham 's/D ME ('1:1), macrophages were exposed to 
each agonist in 1 ml of medium containing 10% feta l bovine serum , as 
fo llows: LPS, 10 p.g/ml ; dena tured type I collagen (gelatin), 10 p.g/ ml; or 
zymosan, 1 mg/ml. After 2 h incubation in the presence of the agonist and 
eicosanoid-synthesis inhibitors , the supernatants were removed for immu-
noassay of PGs and leukotrienes. Cul tures then were refed with fi'esh 
medium and inhibitors. Those cultures exposed to LPS also were refed the 
agonist. Control cultures were treated with the relevant vehicle(s). Dupli-
cate samples were studied in each experiment. Media were assayed for 
.icukotrienes 2 h after stimulation to detect product before its degradation. 
PGE2 also was measured at tius time to document the efficacy ofindoll1etha-
cin treatment. Media were assayed again for PGE2 and meta lloprote inases 
48 h after stimulation. 
Radioimmulloassays and Enzym e-Linked Imnlunosorbellt Assays 
(ELISAs) PGE2 and TX.B2 were determ ined in the supernatants from 
cultured cells by rad ioimmunoassay, and LTB" and LTC, were determined 
by ELISA as described previously (22). Competitive-binding ELISAs for 
human in terstitial collagenase, 92-kDa gelatinasc. and TIMP were per-
formed on conditioned media samples. as described 1 2,23). These assa ys 
have nanogram sensitivity, are completely specifi c for tile respective 
proteins, and measure tota l amounts of each protein whether present in a 
free or bound state (ie, complexes of enzyme-inhibitor, enzyme-substrate). 
Metabolic Labeling and Immunoprecipitation Studies In metabolic 
label ing experiments , cell cul tures were treated as descri bed above for the 
first 24 h of incubation. T he cel l layers then were washed , and otherwise 
identical metitionine-free culture medium (with or without serum dia lyzed 
aga.inst 0.05 M Tris, 0.15 M NaCI. pH 7.5) contamll1g 50 p.Ci/ ml of 
['5S)-methionine was added for ti,e next 24 h. Conditioned media were 
collected and stored at - 80°C for immunoprecipitation oflabeled proteins. 
Polyclonal antisera to human interstitial co llagenase and TlMP were used 
for immunoprecipitation of labeled secreted proteins, as described previ-
ously [4 ,12). The immunoprecipitated proteins were separated by polyacryl-
amide gel electrophoresis, fo llowed by autorad iography (24) using Kodak 
XAJl-5 X-Omat film (Eastman Kodak Co. , Rochester, NY). 
RNA Purification and Analysis Total cellu lar RNA was isolated by the 
guanidinium phenol extr<lction method [25). Northern blot analysis of RNA 
was performed with a collagenase cDNA probe labeled by luck-translation 
to specific activity greater than 2 X 107 cpm. as described previously [26). 
RESULTS 
TIMP, Interstitial Collagenase, and 92-kDa Gelatinase Ex-
pression Are Modulated by Concomitant Synthesis ofPGEz 
T he synth esis of eicosanoids by macrophages is known to be 
modified by the nature of th e inflammatory stimulus. Furthermore, 
the agonist used a lso may affect the pattern of metalJoproteinases 
secreted. T he particulate agonist zymosan enhances leukotriene 
formation, w h ereas t he solubl e agonist bacterial LPS increases the 
synthesis ofPGs m ost effectively [Z7]. A third solub le agonist, type 
I collagen, a matrix component known to stimulate macrophage 
collagenase production , al so was examined [20] . The amounts of 
T IMP, interstitia.l coll agenase, and 9Z- kDa gelatinase secreted in 
t:esponse to each agonist were measured by ELISA. T h e simulta-
neous endogenous synthes is of e icosanoids by cells stimulated with 
these agonists also was dete rmined by specific immun oassay. T he 
effect of eicosanoid produ ction on TIMP and metalloproteinase 
biosynthesis was studied using indomethacin to inhibit cyclooA--Y-
genase activity or MK886 to inhibit leukotrien e fOJ-mation [Z8]. In 
initial experiments, human macrophages were stimulated with 10 
/-Lg/ ml LPS, 10 p.g/ ml denatured type I collagen (gelatin), or 1 
Il1g/ ml zymosan _ The effects of th ese agonists on PG and leuko-
triene formation were documented in supematants obta.ined 2 h 
after th e addition of the agonist, and arc sh own in Table I. We 
observed characteristic stimulation, primari ly ofPGs, by the soluble 
agonist LPS, whereas zymosan was particularly effective in Still1U-
lating LTB4 synth esis_ Denatured type I coll agen (gelatin) appeared 
to function similarly to endotoxin, primari ly increasing the release 
of PGs, although it was less potent at the concentration tested. 
As shown in Fig 1, analysis of 48-h cumulative supernatants 
revealed that aJl three agonists m arkedly induced collagenase 
production, whereas 92-kDa gelatinase was stimulated only mod-
estly. In contrast, TIMP production was primarily stimul ated by 
LPS and was re la tively unaffected by zymosan (Fig 1). T his lack of 
capacity of zymosan to stimu late TIMP expression correlated with 
its mulimal stimu lation of PGE2 or TXB2 (Table I) . Thus, TIMP 
production appeared to be modified particularly by endogenous PG 
synthesis. 
We studied the effect of PG synthesis on the production of 
l11eta\loproteinases by pretreating cultures with 1 J.LM il1dometh acin 
before agOllist exposure. T llis dose of indomethacin was efFective in 
blocking synthesis of PGE2 and TXB2 without toxicity, as deter-
l11ined by immunoassay in each experiment, w hereas lower con-
Table I. Basal and Agonist-Stin'lUlated Synthesis of 
Eicosanoids by Human Macrophagcsn 
Eicosanoid (pgl p.g Proteinl2 h) 
Agonist PGE2 TX.B~ LTB. LTC. 
Basal 0.42 ::': 0.3 1. 0 ::': 0.3 0.8 ::': 0.05 0.3 :t 0 .05 
LPS (10 p.g/ ml) 3.7 ::': 1.9 7.4 ::': 3.7 1.4 ::': 0.23 0.38 :t 0.15 
Gelatin (10 p.g/ml) 1.3 :t 0.8 3.0 :t 1. 9 0.2 :t 0.07 0.2 :t 0.07 
Zymosan (1 mg/ ml) 0.7 ::': 0.25 3.1 ::': 1.2 14.0 :t 2 .0 2.3 :t 0.9 
,r HU1I1;1Il alveolar 111ilc rophagcs were incub<ltcd with th e agonist indicated for 2 h . 
Eicos:mo ids re leased into the medium were quantified as dt!scribcd ill A1atnin/s mId 
lvtt'tilcJds. Dam rcprCSClIf m ea II val lies ::t SEM from three experiments. 
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Figure 1. Production of interstitial collagenase, TIMP, and 92-kDa 
gelatinase in response to agonist stimulation. Macrophagcs wcrc 
incubatcd for 48 h with no agent (control) or in the presen ce ofLPS, gelarin 
(denatured type [ collagen), or zymosan. For each agonist, cultures were 
pretreated with indomethacin 1 /LM (closed bars), indomethacin and PGE2 10- 6 
M (sbaded bm's), or no addition (Opetl bars). Average values of two experiments 
are shown, each performed in duplicate. Cellular protein content was deter-
mined by the bicinchon.ic acid method (Pierce, Rockford, IL). 
centrations werc not. As also shown in Fig 1, when PGE2 
fomlation was decreased by indomethacin treatment, basal an.d 
stimulated synthesis of TIMP, interstitial collagenase, and 92-kDa 
gelatinase all decreased. However, the effect of indomethacin 
treatment on the production of 92-kDa gelatinase was compara-
tively muted. Production ofmetalloproteinases decreased to a lesser 
extent; immunoassay data revealed that some PGE2 synthesis had 
occurred despite indomethacin treatment, suggesting that the syn-
thesis of metalloproteinases could be enhanced by the formation of 
relatively small amounts ofPGs. The response to PGE2 was highly 
specific. Addition of up to 100 nM I-BOP, a stable active analogue 
of TXA2 , or 100 ng/ml of OKY 1587, a stable prostacycli11 
analogue, did not restore the synthesis of TIMP, collagenase, or 
92-kDa gelatinase in the presence of indomethacin (not shown). In 
contrast, PGE2 fully reconstituted inhibitor and metalloenzyme 
production. 
To characterize fully the quantity of PGE2 required to induce 
TIMP and metalloproteinase production, we next examined the 
dose dependence of enzyme and inhibitor expression. LPS-stul1U-
lated macrophages were pretreated with indomethacin to elimUlate 
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endogenous PG synthesis, after which incremental amounts of 
PGE2 were added in concentrations up to 10 -
7 M. The quantity of 
PGE2 added was verified in each experiment by immunoassay. In 
several experiments, very small amounts ofPGE2 were synthesized 
by the cultures despite indomethacul treatment, making it impos-
sible to dctermine enzyme synthesis Ul the complete absence of 
endogenous PGs . Nevertheless, as shown Ul Fig 2, production 
levels of collagenase and TIMP were maximally induced (and 
restored to endogenous LPS-treated levels) by addition of 10 - 8 M 
PGE2 , w hereas 10 -
7 M was required for 92-kDa gelatinase. The 
quantity ofPGE2 needed to restore metalloenzyme production was 
somewhat less than the amount of PGE2 normally synthesized by 
the cultures during the 48-h period studied . The cumulative 
concentration of endogenous PGE2 in the LPS-treated macrophages 
was more than 10- 8 M in nearly all experiments, and often more 
than 10 - 7 M (data not shown). 
Agonist-StiInulated Cellular PGEz Synthesis Determines 
the Quantities of TIMP and Collagenase Produced The 
dose dependence ofTIMP and collagenase production in response 
to PGE2 suggested that synthesis of these proteins resulting from 
agonist exposure might correlate with the capacity of an agonist to 
stimulate PGE2 synthesis. When the 48- h cumulative synthesis of 
PGE2 induced by LPS, gelatin, or zymosan was plotted versus the 
amount of collagenase or TIMP produced by a single subject's 
macrophages, a linear correlation was apparent (Fig 3). No such 
correlation was observed when the relation . between 92-kDa 
gelatinase and PGE2 synthesis was examined (data not shown). 
However, the capacity ofPGE2 to regulate the expression ofTIMP 
and interstitial collagenase was Lmlited. If the spontaneous agonist 
response was poor, exogenous addition ofPGE2 could not increase 
collagenase and TIMP synthesis more th<Ul twofold, uldicatulg an 
Unportant permissive effect of the agonist in controlling the pro-
duction of these proteins (Fig 1) . 
The possible contribution of leukotrienes to the regu lation of 
metalloproteinase biosynthesis was examined using 3 JLM MK886, 
a specific mhibitor of leukotriene formation [26]. Although this 
inhibitor concentration decreased the quantity of LTB4 by more 
than 95%, no consistent effect of MK886 was observed on the 
amount of enzymes produced (data not shown). Thus, leukotrienes 
have no role in regulating metalloenzyme synthesis. Sunilar results 
were obtai.ned w hen nordillydroguaiaritic acid was used; this shows 
that lipoxygenase products such as 15-hydroxyeicosatetraenoic 
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Figure 2. Depcndcnce ofTIMP and 1I1etalloprotcinasc production 
on extracellular PGEz conccntration. At 48 h, cumulativc production 
of interstitial collagenase (opell s'l"arcs), 92-kDa gclatinase (closet/ lria llg/es), 
and TIMP (opell circles) was determincd in indomcthacin-treated cultures to 
wh.ich PGEz was restored in concentrations ranging from 1.0 - 9 M to 10- 7 M 
as indicated. The average values from two cxperiments arc shown, each 
performed in duplicate. 
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Figure 3. Relation of TIMP and collagenase production to the 
endogenous synthesis of PGE2 induced by agonist stimulation. 
Macrophage cumulative synthesis of PGE2 for 48 h was correlated with the 
total production of TI M P or interstitial collagenase over the same period. 
Results show total production of PGE2 , interstitial collagenase , and TIM P 
occurring iJ1 response to LPS 10 iJ.g/ml (triallgles), gelatin 10 iJ.g/ml (circles), 
or zymosan 1 mg/ml (sqllares) in two individuals. Each experiment was 
performed in duplicate . 
acid, an e icosano id product with kno wn immunosuppressive func-
tio ns, do not affect m etallopro te inase synthesis (data not shown) . 
PGEz Regulation of Collagenase and TIMP Production is 
Pretranslational T he m echanism of PGE2 regulation of m etal-
loproteinase expression was studied further by immunoprecipita-
tion of [3sS]_labeled , secre ted prote ins using antisera specific for 
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Figure 4. The LPS-stimulated biosynthesis of TIMP is suppressed 
by indomethacin and restored by exogenously added PGE2 • Human 
macrophages were labeled metaboljcally with [" S1-methionjne, as de-
scribed in NIetlwds, alld newly synthesized proteins were immunoprecipi-
tated with T IMI)-specific antiserum . C ul turcs were stimulated with 10 
iJ.g/ml LPS (lanes 4-6) . LPS-stimula ted synthes is ofTIMP was abolished by 
treatment with 10- 6 M indomethacin (I) , but was res tored when 10- 6 M 
PGE2 (E2 ) was added to the indomcthacin-treated cell s. C , control. 
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Figure 5. The LPS-stimwated biosynthesis of interstitial collage-
nase is suppressed by indomethacin and restored by exogenously 
added PGE2 • Human macrophages were labeled metabolically with CSSl-
methionine, as described in Methods, and newly synthesized proteins were 
immunoprecipitated with interstitial-collagenase-specific antiserum. Cul-
tures were stimulated with 10 /-Lg/ml LPS (lanes 5-7) . LPS-stimulated 
synthesis of interstitial colbgenase was markedly decreased by treaon ent 
with 10- 6 M indomethacin (I), but was restored when 10- 6 M PGE2 (E2) 
was added to the indomethacin-treated cell s. C, control. 
TIMP (Fig 4) and collagen ase (Fig 5) . A minimal effect of PGE2 
addition on T IMP or collagenase syn th esis w as observed in the 
absen ce of LPS. T h e extent of tlus PGE 2-induced synth esis va ried 
with the subject , with approx imately half o f individu als £Liling to 
produce TIMP or collagen ase w ithout the concomitant addition o f 
LPS. A substantial increase in both T IMP and collagen ase syntllesis 
w as observed w hen cultures were stimulated w ith LPS . lndom etll a-
ci..n treatment potently blocked th e LPS-induced synth esis of bo th 
coUagenase and its inlubitor, and PGE2 res to re d their production 
de spite the presen ce of indomethacin. Becau se of the sensitivity o f 
TIMP and collagen ase syn thesis to sma]] quantities o f endogenously 
formed PGs , the degree of inlubition observed varied with th e 
extent to which indo m ethacin w as successful in blocking P G 
synthesis. Because indomethacin was re-added to the cul tures 
immediate ly b efore the addition o f the radio lab el, these immuno-
precipita tion exp eriments resulted in som ewhat stronger inhibi tion 
o f collagenase and T IMP synthesis than th e 48-h cumulative 
exp eriments assayed by ELrSA (Fig 1), 
T h e m echanisms of P G regulation of collagen ase and T IMP 
biosyntllesis w ere ex amined further by N o rthem blot an alysis of 
total mRNA from control and LPS- stimulated m acrophages (Fig 
6) . As has been reported previously [5], n o detectable inte rstitial 
collagen ase mRNA was found in unstimul ated cells. W h en cul tures 
w e re exposed to LPS , a pron ounced accumulation of collagen ase 
mRNA w as o bserved , which w as virtu ally e liminated by indo-
m e thacin treatment , Collagen ase m.RNA levels were restored fuJIy 
when PGE2 w as added to the LPS-stimulated , indom ethacin-
tre ated cultures. 
TIMP mRNA was no t de tected b asally but w as found in 
mode ra te amounts from cultures treated w ith exogen ous PGE2 , 
even in the absence o f LPS. T he addi tion of LPS greatly increased 
th e qu anti ty of T IMP m essage de tected , w hich was supp ressed 
partially (appro;\,;mately 30% by scanning densitom etry) in the 
presen ce of indomethacin . P GE2 addition [ 0 indom etllacin-treated 
cells fully restored TIMP mRNA levels in a patte rn similar to that 
observed fo r ELrSA and il11mullop recipi tation exp eriments. 
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Figure 6. Pre translational control of PG effects on interstitial 
collagenase and TIMP production. Human macrophages were treated 
as described in Mel llOds, and total RNA was harvested and subjected to 
Northern ana lysis. The blot was probed w ith radiolabeled collagenase and 
TIMP cDNAs. The blot thcn was reprobed with glyceraldehydc-3-phos-
phatc dehydrogenase (GAPDH) eDNA. The relative levels of collagenase 
and TIMP to GAPDH mRNA were calculated by scanning densitometry. 
Cont, control; I, 10- 6 M indomethacin; E2 , 10-
6 M PGE2 ; LPS, 10 J.l.g/ml 
LPS . 
DISCUSSION 
In this report, we have studied the eicosanoid dependence of 
metalloproteinase and T IMP expression ill the hum an tissue mac-
rophage. We have shown previously that tissue macrophage pro-
duction of metalloproteinases and TIMP is found in granuloma 
annulare [1] and necrobiosis Lipoidica diabeticorum [1], and also is 
found in nonheaLing ulcers [2]. To study the tissue macrophage, we 
have used th e human alveolar macrophage as a prototypic cell. Thjs 
represents a standard approach in macrophage biology because pure 
populations of cells can be obtained in considerable quantity, in 
contrast to other tissues such as the skin . Although it is not certajn 
that the properties of the alveolar macrophage are identical to those 
of the skin macrophage, no method currently exists for obtaining 
skin macrophages in numbers sufficient for study . Furthermore, the 
alveolar macrophage is widely believed to resemble the tissue 
macrophage more closely than does a monocyte-derived macro-
phage (differentiated ill vitro). We have found that all agonists 
tested, particulate and solubl e, substrate and non substrate, regulate 
cellular TIMP and metalloproteinase production by conconutant 
endogenous PGE2 synthesis. Synthesis of LTB4 , LTC4 , and stable 
analogues ofTXA2 and prostacyclin all were ineffective ill regulat-
ing metalloenzyme or TIMP expression. 
The regulatory effect of PGE2 was most pronounced for collag-
enase expression, in whjch indomethacin treatment routinely sup-
pressed biosynthesis of the enzyme by 70%. Macrophage T IMP 
expression also was regulated through endogenous synthesis of 
PGE2 , with levels of TIMP decreasing an av.erage of 65% in the 
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presence of indomethacin . T hese results are the first demonstration 
that th e signal transduction pathway for macrophage T IMP pro-
duction also is dependent upon cellul ar PGEz synthesis, as has been 
shown previously for collagenase [1 6-20]. It is interesting that the 
variability in suppression of TIMP and metalloproteinase biosyn-
thesis observed from experiment to experiment corre lated with the 
degree of inhibition of endogenous PG synthesis exerted by indo-
methacin treatment. Although larger doses of indomethacin can 
suppress PG synthesis completely, cell toxicity occurs. Production 
of 92-kDa gelatinase also was influenced by indomethacin treat-
m ent and the exogenous addition ofPGEz. However, this enzyme's 
secretion was not tightly correlated with the cells' spontaneous 
synth esis of PGE2 , possibly because 10-fold more PGE2 was re-
quired to enhance the production of92-kDa gelatinase as compa red 
to collagenase. The resistance of macrophage 92-kDa gelatinase 
production to control via PGE2 contrasts with the relative ease of 
regulation of this enzyme by PG synthesis in interl eukin-4 -treated 
monocytes, where 10- ij M PGE2 was sufficient to overcome 
interl eukin-4-mediated inhibition of gelatinase production [16] . 
It has been demonstrated that the net collagenolytic activity 
released by stimulated monocytes can be inhibited by indomethacin 
and restored by PGE2 or agents with cyclic adenosine monophos-
phate agonist activity. In addition, the inhibi tory effects of inter fe r-
on-gamma and interleuk.iJ1-4 on monocyte collagenase activ ity can 
be reversed by addition ofPGE2 [1 6-19]. T he mechanism by which 
indomethacin inhibits collagenolysis therefore has been attributed 
to suppression of interstitial collagenase and '92-kDa gelatinase 
production, as no effects ofPGEz on T IMP synthesis were observed 
[16]. T hese results contrast greatly with those reported here, 
perhaps because PG-dependent regulation of collagenolysis may be 
cell-type-specific, even between the tissue macrophage and its 
progenitor cell , the blood monocyte. We have found that in human 
tissue macrophages, under basal conditions or after agonist stimu-
lation, TIMP production is regulated by PGE2 synthesis nearly as 
effectively as collagenase, whereas 92-kDa gelatinase is compara-
tively resistant to PG effects. Indeed, PG-dependent regulation of 
T IMP production is part of the response pathway in all three 
agonists tested, and their stimulatory capacity is directly propor-
tional to the total quantity ofPGE2 accumulating in response to the 
agonist over the 48-h period studied. T he data presented here using 
soluble, substrate, and particulate agonists of macrophage eico-
san oid formation expand the list of agonists that stin1Ulate metal-
loproteinase production through a PG-dependent mechanism. O ur 
results also suggest that PGE2 participates in a final common 
pathway through which aU regulatory agents must act to alter the 
extracellular-matrix- degradin g capacity of tissue macrophages. 
T h e regulation of T IMP and metall oprote inase production by 
eicosanoids is highly selective for PGEz, as no other macrophage 
eicosanoid product was capable of restoring sY1lth esis in the pres-
ence of indomethacin under the conditions tested . 
]n addit ion to dissecting the role of eicosanoids in controlling the 
expression of individual enzymes that contribute to the macro-
phage's matrix-degrading activities, we studied the mechanism by 
w hich this regulation occurs. Because T IMP and interstitial colla-
genase synthesis were most responsive to regulation by endogenous 
PGE2 levels, we addressed the ce llular mechanisms regulating the 
expression of these proteins in response to PGE2 . Synthesis of 
secreted e SS]-methionine-labeled collagenase in response to LPS 
was markedly decreased in the presence of indomethacin, and fully 
restored when PGE2 was added. T hese effects were consistent and 
obvious, in part because basal sY1lthesis of coll agenase is so low. 
Such changes in protein sY1lthesis were largely paralleled by 
changes in steady-state collagenase mRNA levels, indicating that 
PGE2 acts pretranslationally to affect cellular collagenase biosyn-
thesis . In the case of T IMP, LPS-induced biosynthesis also was 
suppressed by indomethacin and restored by PGE2 , as shown by 
metabolic labeling/immllnoprecipitation experiments (F ig 4). 
However, pretranslational regulation of T IMP was more variable 
because substantial basal TIMP synthesis occurred, even in the 
presence of indomethacin, in some cultures. T hese results suggest 
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that T IMP synthesis also may proceed via a pathway that is 
PG-independent and is expressed to varying degrees among indi-
vidual macrophage donors. Further studies are needed to clarifY the 
regulatory m echanisms of such a pathway. 
T he regulation of inflammatory-cell metalloproteinase expres-
sion by PGE2 may explain the benefit derived from the usc of 
nonste roidal anti-inflammatory agents in systemic diseases such as 
arthritis and in cutaneous pathologic states such as erythema 
nodosum. However, the small quantity of PGE2 required for full 
expression of collagenase and TIMP synthesis, and the coordin ate 
regulation of these proteins by PGE2 , may accowlt for the limited 
success of this therapeutic approach . A search for improved agents 
to control PG sY11thesis in areas of inflammation therefore ma)' be 
warranted, but their anti-PG activities will have to approach 
absolute. 
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